Researchers in China report that global incidence rates of psoriasis rose slightly from 1990 to 2021 and are projected to ...

Psoriasis is a chronic, immune-mediated skin condition. It causes red, scaly, itchy, often inflamed patches. Because the ...

The global psoriasis burden shows a slight increase from 1990 to 2021 and is projected to rise further by 2050.

The blogger Howard Chang explores the latest advancements bringing hope for a psoriasis cure, some of which were presented at a community event.

For people with psoriasis — a chronic skin disease in which skin cells build up, typically causing discolored, itchy or scaly patches — living with the condition itself is difficult enough. But on top ...

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the treatment of plaque psoriasis. We conducted a phase 3, double-blind, randomized, ...

About Plaque Psoriasis Plaque psoriasis (PsO) is a chronic immune-mediated disease resulting in overproduction of skin cells, which causes inflamed, scaly plaques that may be itchy or painful. It is ...

The ICONIC-ADVANCE 1 and 2 studies assessed the superiority of icotrokinra compared to deucravacitinib in patients with moderate-to-severe plaque psoriasis. As previously announced, in the studies ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...